History at HistoRx

(3/15/2010) A New Haven-based bioscience company has secured a $1.5 million loan from Connecticut Innovations, the state's quasi-public authority responsible for technology investing.

HistoRx Inc., which is developing and commercializing a diagnostic technology to aid in cancer treatment, will use the money to build out laboratory space and purchase new equipment.

The five-year-old company has developed a technology that quantifies specific protein expression within different parts of the cells in cancerous tissue samples. The information allows researchers and clinicians to determine which drugs may be best suited to fight a particular patient's cancer, while more accurately predicting a patient's response to treatment, the company said.

The AQUA platform, as the technology is known as, uses fluorescence-based image analysis with automated microscopy to measure protein molecules.

CI is providing the loan through its BioScience Facilities Fund, which was established in 1998, and has facilitated the creation of more than 330,000 square feet of new laboratory and related space in the state.

Follow this link for more information.